Tudor Investment Corporation »

Taysha Gene Therapies shares owned by Tudor Investment Corporation

Quarter-by-quarter ownership of Taysha Gene Therapies (TSHA) shares owned by Tudor Investment Corporation from 13F filings

Historical chart of Tudor Investment Corporation investment in Taysha Gene Therapies

Tip: Access up to 7 years of quarterly data

All positions including Taysha Gene Therapies held by Tudor Investment Corporation consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Taysha Gene Therapies by Tudor Investment Corporation

Quarter filed Position value Share count Share price at filing
2026-03-31 $642k 144k 4.47
2024-06-30 $60k 27k 2.24
2020-09-30 $218k 9.7k 22.42

More positions owned by Tudor Investment Corporation

Ishares Russell 2000 Etf - US ETP ETF Option Call Option (IWM)
Invesco Qqq Trust Series 1 - US ETP ETF Option Call Option (QQQ)
State Street SPDR S&P 500 ETF Trust - US ETP ETF Option Call Option (SPY)
Spdr Gold Shares - US ETP ETF Option Call Option (GLD)
Nvidia Corp - US Equity (NVDA)
State Street Energy Select Sector SPDR ETF - US ET ETF Option Call Option (XLE)
Ishares Msci Emerging Markets Etf - US ETP ETF Option Call Option (EEM)
Microsoft Corp - US Equity (MSFT)
State Street Financial Select Sector SPDR ETF - US ETF Option Call Option (XLF)
Tesla Inc - US Equity (TSLA)
Ishares China Large-Cap Etf - US ETP ETF Option Call Option (FXI)
Meta Platforms Inc - US Equity (META)
Taiwan Semiconductor Manufacturing Co Ltd - US Depository Receipt (TSM)
Alibaba Group Holding Ltd - US Depository Receipt (BABA)
Amazon.Com Inc - US Equity (AMZN)

View all positions for Tudor Investment Corporation

Top funds holding Taysha Gene Therapies

RA Capital Management
Goldman Sachs Group
venBio Select Advisor
BlackRock
Vestal Point Capital
Morgan Stanley
FMR
Rtw Investments
Vanguard Group
State Street Corporation
Vanguard Capital Management
Octagon Capital Advisors
Siren
Polar Capital Holdings
Geode Capital Management

View all funds holding Taysha Gene Therapies